Yayın:
Urticaria and angio-oedema due to ziprasidone

dc.contributor.buuauthorAkkaya, Cengiz
dc.contributor.buuauthorSarandöl, Aslı
dc.contributor.buuauthorAydoğan, Kenan
dc.contributor.buuauthorKirli, Selçuk
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPsikiyatri Ana Bilim Dalı
dc.contributor.departmentDermatoloji Ana Bilim Dalı
dc.contributor.scopusid14061855100
dc.contributor.scopusid14020405100
dc.contributor.scopusid9739755800
dc.contributor.scopusid14019745700
dc.date.accessioned2022-09-16T12:07:55Z
dc.date.available2022-09-16T12:07:55Z
dc.date.issued2007-07
dc.description.abstractAntipsychotic medications are commonly associated with adverse cutaneous reactions (ACRs) in approximately 5% of patients. Angio-oedema accompanying unticaria is one of the most serious ACRs. The 36-year-old female patient who was diagnosed with 'Paranoid schizophrenia' 6 years ago, was commenced on ziprasidone 120 mg/day. On day 30 of the treatment, the patient presented urticarial papules and plaques all over the body and angio-oedema in the face. The patient was diagnosed as 'Urticaria+Angio-oedema'. The development of ACRs after the initation of ziprasidone monotherapy, disappearance of Lesions after the discontinuation of this antipsychotic, and positive intradermal skin test all suggests a possible causal relationship between ACRs and ziprasidone. To our knowledge, this is the first reported case of unticaria and angio-oedema due to ziprasidone monotherapy. Ziprasidone is a valid and effective choice amongst antipsychotic medications, but this case calls for caution regarding ACRs at the time of prescribing.
dc.identifier.citationAkkaya, C. vd. (2007). "Urticaria and angio-oedema due to ziprasidone". Journal of Psychopharmacology, 21(5), 550-552.
dc.identifier.doi10.1177/0269881106075273
dc.identifier.endpage552
dc.identifier.issn1461-7285
dc.identifier.issn0269-8811
dc.identifier.issue5
dc.identifier.pubmed17446198
dc.identifier.scopus2-s2.0-34547124577
dc.identifier.startpage550
dc.identifier.urihttps://doi.org/10.1177/0269881106075273
dc.identifier.urihttps://journals.sagepub.com/doi/10.1177/0269881106075273
dc.identifier.urihttp://hdl.handle.net/11452/28790
dc.identifier.volume21
dc.identifier.wos000248793200013
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSage Publications
dc.relation.journalJournal of Psychopharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAngio-oedema
dc.subjectAdverse cutaneous reactions
dc.subjectRisperidone
dc.subjectUrticaria
dc.subjectZiprasidone
dc.subject.emtreeAdult
dc.subject.emtreeBetamethasone sodium phosphate
dc.subject.emtreeBiperiden
dc.subject.emtreeFexofenadine
dc.subject.emtreeHaloperidol
dc.subject.emtreePheniramine maleate
dc.subject.emtreeZiprasidone
dc.subject.emtreeZuclopenthixol
dc.subject.emtreeArticle
dc.subject.emtreePriority journal
dc.subject.emtreeAngioneurotic edema
dc.subject.emtreeDrug withdrawal
dc.subject.emtreePhysical examination
dc.subject.emtreeCase report
dc.subject.emtreeCausal attribution
dc.subject.emtreeConsultation
dc.subject.emtreeDermatology
dc.subject.emtreeDrug dose increase
dc.subject.emtreeFemale
dc.subject.emtreeParanoid schizophrenia
dc.subject.emtreeFace edema
dc.subject.emtreeHuman
dc.subject.emtreeMonotherapy
dc.subject.emtreePapule
dc.subject.emtreeInvoluntary movement
dc.subject.emtreeRigidity
dc.subject.emtreeSide effect
dc.subject.emtreeSingle drug dose
dc.subject.emtreeSkin test
dc.subject.emtreeSymptom
dc.subject.emtreeUrticaria
dc.subject.meshAntipsychotic agents
dc.subject.meshAdult
dc.subject.meshAngioneurotic edema
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshPiperazines
dc.subject.meshSchizophrenia, paranoid
dc.subject.meshThiazoles
dc.subject.meshUrticaria
dc.subject.scopusDexamphetamine; Edema; Adrenergic Receptor Stimulating Agent
dc.subject.wosClinical neurology
dc.subject.wosNeurosciences
dc.subject.wosPharmacology & pharmacy
dc.subject.wosPsychiatry
dc.titleUrticaria and angio-oedema due to ziprasidone
dc.typeArticle
dc.wos.quartileQ1
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Psikiyatri Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Dermatoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama